Overall rank by patents
#27,848
of 49,997 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Xenco ranks #27,848 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R27848 · US Corporation #27,848 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Xallent Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Xenco Medical · this assignee
50 score
3D Lighting… · lowest
7 score
What this shows Xenco's Innovation Score is 49.6/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Xenco Medical, LLC is a focused PatentsView assignee: 7 CPC subclasses with 90% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2016. By volume, Xenco sits between Xuzhou Coal Mine Safety Equipment Manufacture Co., Ltd. and Xona Space Systems Inc..
Xenco Medical, LLC shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Xuzhou Coal Mine Safety Equipment Manufacture Co., Ltd.
10 patents
Xallent Inc.
10 patents
Xamarin Inc.
10 patents
Xcad Valve & Irrigation, Inc.
10 patents
Xenomatix NV
10 patents
Xiamen Worthfind Industrial Co., Ltd.
10 patents
Xilis, Inc.
10 patents
Xona Space Systems Inc.
10 patents
Xenco Medical, LLC
10 patents
What this shows Xenco holds 10 patents at rank #27,847, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,847 in granted patent volume.
Other assignees with the most granted patents in Xenco's primary technology class.
Xenco's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
50 Top 14% higher than 86% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 10.0% |
| 2017 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2022 | 2 | 20.0% |
| 2023 | 1 | 10.0% |
| 2024 | 2 | 20.0% |
| 2025partial year | 2 | 20.0% |
Top 7 of 7 technology areas
Overall rank by patents
#27,848
of 49,997 tracked assignees
49.6 out of 100
What to do with this data
Xenco Medical, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.